デフォルト表紙
市場調査レポート
商品コード
1746960

日本の新生児スクリーニング市場の分析:製品別、技術別、検査の種類別、地域別(2025~2033年)

Japan Newborn Screening Market Report by Product, Technology, Test Type, and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 121 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.72円
日本の新生児スクリーニング市場の分析:製品別、技術別、検査の種類別、地域別(2025~2033年)
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 121 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の新生児スクリーニングの市場規模は2024年に6,440万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに1億750万米ドルに達し、2025年から2033年の間に5.9%の成長率(CAGR)を示すと予測しています。より正確な治療結果と効率的な疾患検出のための医療技術における継続的な技術革新が、主にこの地域市場を牽引しています。

当レポートで扱う主な質問

  • 日本の新生児スクリーニング市場はこれまでどのように推移し、今後どのように推移するのか?
  • COVID-19が日本の新生児スクリーニング市場に与えた影響は?
  • 日本の新生児スクリーニング市場の製品別の内訳は?
  • 日本の新生児スクリーニング市場の技術別の内訳は?
  • 日本の新生児スクリーニング市場の検査の種類別の内訳は?
  • 日本の新生児スクリーニング市場のバリューチェーンにおける様々なステージとは?
  • 日本の新生児スクリーニングにおける主要な促進要因と課題は何か?
  • 日本の新生児スクリーニング市場の構造と主要企業は?
  • 日本の新生児スクリーニング市場における競合の程度は?

目次

第1章 序文

第2章 分析範囲・手法

  • 分析目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 分析手法

第3章 エグゼクティブサマリー

第4章 日本の新生児スクリーニング市場:概要

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の新生児スクリーニング市場の情勢

  • 過去・現在の市場動向(2019~2024年)
  • 市場予測(2025~2033年)

第6章 日本の新生児スクリーニング市場:製品別の内訳

  • 機器
  • 試薬

第7章 日本の新生児スクリーニング市場:技術別の内訳

  • タンデム質量分析法
  • パルスオキシメトリー
  • 酵素ベースのアッセイ
  • DNA検査
  • 電気泳動
  • その他

第8章 日本の新生児スクリーニング市場:検査の種類別の内訳

  • ドライブラッドスポットテスト
  • CCHD
  • 聴覚スクリーン

第9章 日本の新生児スクリーニング市場:競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要な成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第10章 主要企業のプロファイル

第11章 日本の新生児スクリーニング市場:業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第12章 付録

目次
Product Code: SR112025A19397

Japan newborn screening market size reached USD 64.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 107.5 Million by 2033, exhibiting a growth rate (CAGR) of 5.9% during 2025-2033. Continuous innovations in medical technology for more accurate outcomes and efficiency of disease detection are primarily driving the regional market.

Newborn screening encompasses a series of laboratory assessments and point-of-care examinations designed for the early detection, diagnosis, and intervention of genetic, metabolic, hematological, or hormonal disorders that may not manifest immediately after birth. The primary objective is to identify diseases that have the potential to cause significant morbidity, mortality, and intellectual disability (ID) at an early stage, enabling prompt initiation of treatment before symptoms become evident. The typical newborn screening process involves the collection of a small blood sample from the baby's heel, which is subjected to a straightforward blood test. Subsequently, the blood sample undergoes testing to assess various conditions, including metabolic disorders, endocrine irregularities, and blood-related ailments such as phenylketonuria (PKU), cystic fibrosis, and sickle cell anemia. Should the initial screening results suggest a genetic disorder in the newborn, additional confirmatory testing becomes necessary to validate the diagnosis. This enables timely administration of appropriate treatment and the establishment of a follow-up care plan for the infant's well-being.

Japan Newborn Screening Market Trends:

The Japan newborn screening market is witnessing significant growth, primarily driven by heightened parental concerns for their children's health, especially among new parents. This concern is rooted in the increasing prevalence of congenital conditions in infants. Parents are becoming more aware of the critical role early detection and diagnosis play in facilitating timely medical intervention and treatment, further propelling the market's expansion. Advancements in medical technology and genetic testing have significantly broadened the range of disorders that can be screened for, enhancing the market's prospects. Governments and healthcare organizations are increasingly adopting newborn screening programs, adding to the market's positive trajectory. Ongoing product innovations, such as the integration of next-generation sequencing and tandem mass spectrometry, offer improved screening accuracy and speed, further bolstering market growth. The availability of direct-to-consumer genetic testing and a growing focus on personalized medicine are driving tailored treatments tailored to individuals' specific genetic profiles, further stimulating market demand. Factors such as increased healthcare expenditure, rapid digitization, higher internet speeds, the emergence of online health communities, and extensive research and development (R&D) efforts will contribute to the market's overall growth and advancement over the forecasted period.

Japan Newborn Screening Market Segmentation:

Product Insights:

  • Instruments
  • Reagents

Technology Insights:

  • Tandem Mass Spectrometry
  • Pulse Oximetry
  • Enzyme Based Assay
  • DNA Assay
  • Electrophoresis
  • Others

Test Type Insights:

  • Dry Blood Spot Test
  • CCHD
  • Hearing Screen

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan newborn screening market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan newborn screening market?
  • What is the breakup of the Japan newborn screening market on the basis of product?
  • What is the breakup of the Japan newborn screening market on the basis of technology?
  • What is the breakup of the Japan newborn screening market on the basis of test type?
  • What are the various stages in the value chain of the Japan newborn screening market?
  • What are the key driving factors and challenges in the Japan newborn screening?
  • What is the structure of the Japan newborn screening market and who are the key players?
  • What is the degree of competition in the Japan newborn screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Newborn Screening Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Newborn Screening Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Newborn Screening Market - Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Reagents
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)

7 Japan Newborn Screening Market - Breakup by Technology

  • 7.1 Tandem Mass Spectrometry
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Pulse Oximetry
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Enzyme Based Assay
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 DNA Assay
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Electrophoresis
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2019-2024)
    • 7.5.3 Market Forecast (2025-2033)
  • 7.6 Others
    • 7.6.1 Historical and Current Market Trends (2019-2024)
    • 7.6.2 Market Forecast (2025-2033)

8 Japan Newborn Screening Market - Breakup by Test Type

  • 8.1 Dry Blood Spot Test
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 CCHD
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Hearing Screen
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)

9 Japan Newborn Screening Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Newborn Screening Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix